Literature DB >> 30840165

What does risk of future cancer mean to breast cancer patients?

Karen Kaiser1, Kenzie A Cameron2,3, Jennifer Beaumont4, Sofia F Garcia2, Leilani Lacson2, Margaret Moran5, Lindsey Karavites6, Chiara Rodgers7, Swati Kulkarni8, Nora M Hansen8, Seema A Khan8.   

Abstract

PURPOSE: Newly diagnosed breast cancer patients greatly overestimate their risk of developing contralateral breast cancer (CBC). Better understanding of patient conceptions of risk would facilitate doctor-patient communication and surgical decision making. In this mixed methods study, we prospectively examined breast cancer patients' perceived risk of future cancer and the reported factors that drove their risk perceptions.
METHODS: Women age 21-60 diagnosed with breast cancer without a BRCA mutation or known distant metastases completed a study interview between surgical consult and surgical treatment. Participants completed a 12-item Perceived Risk Questionnaire, which assessed 10-year and lifetime risks of ipsilateral local recurrence, CBC, and distant recurrence. Patients provided qualitative explanations for their answers.
RESULTS: Sixty-three patients completed study interviews (mean age 50.3). Participants were primarily White (85.7%) and 90.5% had attended college. Patients estimated their 10-year risk of CBC as 22.0%, nearly 4 times the established 10-year risk. Women attributed their risk perceptions to "gut feelings" about future cancer, even when women knew those feelings contradicted medically established risk. Perceptions of risk also reflected beliefs that cancer is random and that risk for local recurrence, CBC, and distant recurrence are the same.
CONCLUSIONS: Our findings point to the need for novel ways of presenting factual information regarding both risk of recurrence and of new primary cancers, as well as the necessity of acknowledging cognitive and affective processes many patients use when conceptualizing risk. By differentiating women's intuitive feelings about risk from their knowledge of medically estimated risk, doctors can enhance informed decision making.

Entities:  

Keywords:  Breast cancer; Contralateral prophylactic mastectomy; Patient education; Risk

Mesh:

Year:  2019        PMID: 30840165      PMCID: PMC6535122          DOI: 10.1007/s10549-019-05182-3

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  29 in total

1.  Affect, risk, and decision making.

Authors:  Paul Slovic; Ellen Peters; Melissa L Finucane; Donald G Macgregor
Journal:  Health Psychol       Date:  2005-07       Impact factor: 4.267

2.  Objective and subjective breast cancer risk: relationships with natural killer cell activity and psychological distress in healthy women.

Authors:  Na-Jin Park; Duck-Hee Kang; Michael T Weaver
Journal:  Cancer Nurs       Date:  2010 Nov-Dec       Impact factor: 2.592

Review 3.  Supporting informed consumer health care decisions: data presentation approaches that facilitate the use of information in choice.

Authors:  Judith H Hibbard; Ellen Peters
Journal:  Annu Rev Public Health       Date:  2001-11-06       Impact factor: 21.981

4.  Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials.

Authors: 
Journal:  Lancet       Date:  2005 May 14-20       Impact factor: 79.321

5.  A comparison of risk perception and psychological morbidity in women with ductal carcinoma in situ and early invasive breast cancer.

Authors:  Eileen Rakovitch; Edmee Franssen; John Kim; Ida Ackerman; Jean-Philippe Pignol; Lawrence Paszat; Kathleen I Pritchard; Cindy Ho; Donald A Redelmeier
Journal:  Breast Cancer Res Treat       Date:  2003-02       Impact factor: 4.872

6.  Subjective versus objective risk in genetic counseling for hereditary breast and/or ovarian cancers.

Authors:  Anita Caruso; Cristina Vigna; Bruna Marozzo; Fabio M Sega; Isabella Sperduti; Francesco Cognetti; Antonella Savarese
Journal:  J Exp Clin Cancer Res       Date:  2009-12-21

7.  Subjective and objective risk of breast cancer in Ashkenazi Jewish individuals at risk for BRCA1/2 mutations.

Authors:  Kimberly Kelly; Howard Leventhal; Monica Marvin; Deborah Toppmeyer; Judith Much; James Dermody; Jill Baran; Marvin Schwalb
Journal:  Genet Test       Date:  2004

8.  Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer.

Authors:  Stewart J Anderson; Irene Wapnir; James J Dignam; Bernard Fisher; Eleftherios P Mamounas; Jong-Hyeon Jeong; Charles E Geyer; D Lawrence Wickerham; Joseph P Costantino; Norman Wolmark
Journal:  J Clin Oncol       Date:  2009-04-06       Impact factor: 44.544

9.  Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study.

Authors:  Xiang Gao; Susan G Fisher; Bahman Emami
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-07-15       Impact factor: 7.038

10.  Accuracy of perceived risk of recurrence among patients with early-stage breast cancer.

Authors:  Ying Liu; Maria Pérez; Rebecca L Aft; Kerry Massman; Erica Robinson; Stephanie Myles; Mario Schootman; William E Gillanders; Donna B Jeffe
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-02-16       Impact factor: 4.254

View more
  4 in total

1.  A Systematic Review of Estimating Breast Cancer Recurrence at the Population Level With Administrative Data.

Authors:  Hava Izci; Tim Tambuyzer; Krizia Tuand; Victoria Depoorter; Annouschka Laenen; Hans Wildiers; Ignace Vergote; Liesbet Van Eycken; Harlinde De Schutter; Freija Verdoodt; Patrick Neven
Journal:  J Natl Cancer Inst       Date:  2020-10-01       Impact factor: 13.506

2.  Longitudinal Study of Psychosocial Outcomes Following Surgery in Women with Unilateral Nonhereditary Breast Cancer.

Authors:  David W Lim; Helene Retrouvey; Isabel Kerrebijn; Kate Butler; Anne C O'Neill; Tulin D Cil; Toni Zhong; Stefan O P Hofer; David R McCready; Kelly A Metcalfe
Journal:  Ann Surg Oncol       Date:  2021-04-05       Impact factor: 5.344

3.  Analysis of a Trend Reversal in US Lumpectomy Rates From 2005 Through 2017 Using 3 Nationwide Data Sets.

Authors:  Jonas A Nelson; Robyn N Rubenstein; Kathryn Haglich; Jacqueline J Chu; Shen Yin; Carrie S Stern; Monica Morrow; Babak J Mehrara; Mary L Gemignani; Evan Matros
Journal:  JAMA Surg       Date:  2022-08-01       Impact factor: 16.681

4.  The risk of contralateral breast cancer: a SEER-based analysis.

Authors:  Vasily Giannakeas; David W Lim; Steven A Narod
Journal:  Br J Cancer       Date:  2021-05-26       Impact factor: 9.075

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.